X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
0
https://endpts.com/ftc-says-patent-battle-over-parkinsons-drug-could-have-significant-implications-for-patients/
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=11202310416
https://www.biopharmadive.com/news/supernus-fda-rejection-parkinsons-crl/633685/
https://www.prnewswire.com/news-releases/trupharma-llc-announces-approval-and-launch-of-apomorphine-hydrochloride-cartridges-30-mg3-ml-10-mgml-the-first-generic-version-of-apokyn-cartridges-301492707.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212025
https://www.globenewswire.com/news-release/2022/02/22/2389258/19871/en/Supernus-Receives-Notice-Assigning-Early-October-2022-PDUFA-for-SPN-830-Apomorphine-Infusion-Device-NDA.html
https://www.biospace.com/article/releases/sunovion-announces-the-commercial-launch-of-kynmobi-apomorphine-hydrochloride-sublingual-film-for-the-treatment-of-parkinson-s-disease-off-episodes/
https://www.biospace.com/article/releases/sunovion-announces-health-canada-approval-of-kynmobi-apomorphine-hydrochloride-soluble-film-for-the-treatment-of-parkinson-s-disease-off-episodes/
https://www.businesswire.com/news/home/20200521005786/en/Sunovion-Announces-U.S.-FDA-Approval-KYNMOBI%E2%84%A2-apomorphine
https://endpts.com/parkinsons-patients-experiencing-off-episodes-no-longer-need-to-rely-on-a-needle-for-an-antidote-with-new-fda-approval/
https://www.globenewswire.com/news-release/2020/04/28/2023750/0/en/Supernus-to-Acquire-CNS-Portfolio-from-US-WorldMeds.html
https://www.in-pharmatechnologist.com/Article/2019/02/04/Sunovion-receives-CRL-for-its-Parkinson-s-NDA
https://pharmaphorum.com/news/sunovions-parkinsons-disease-drug-step-closer-approval/
https://www.drugdeliverybusiness.com/fda-to-review-sunovions-apomorphine-sublingual-film-for-parkinsons-disease/
Market Place
Share 
